Biomarkers and surrogate endpoints in cardiovascular therapeutics research: under scrutiny following results of the ENHANCE Study. [electronic resource]
Producer: 20080909Description: 85-8 p. digitalISSN:- 1755-5914
- Anticholesteremic Agents -- therapeutic use
- Azetidines -- therapeutic use
- Biomarkers
- Biomarkers, Pharmacological -- blood
- C-Reactive Protein -- metabolism
- Carotid Arteries -- drug effects
- Cholesterol, LDL -- blood
- Clinical Trials as Topic
- Drug Combinations
- Ezetimibe, Simvastatin Drug Combination
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors -- therapeutic use
- Hypercholesterolemia -- blood
- Reproducibility of Results
- Simvastatin -- therapeutic use
- Treatment Outcome
No physical items for this record
Publication Type: Editorial
There are no comments on this title.
Log in to your account to post a comment.